Endurant Capital Management LP X4 Pharmaceuticals, Inc Transaction History

Endurant Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$4.53 - $6.45 $321,489 - $457,750	-70,969 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.49 - $9.56 $525,865 - $774,618	-81,027 Reduced 53.31%	70,969 $461,000
Q1 2021 May 17, 2021	BUY	$6.63 - $10.28 $1.01 Million - $1.56 Million	151,996 New	151,996 $1.31 Million

99.6M

421K

80.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $21.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.